Search Results 471-480 of 24183 for prostate cancer

  1. Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer - Mayo Clinic

    The purpose of this study is to test how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and who have ...

  2. A Study Using Gallium-68 PSMA-11 and C-11 Choline PET Imaging to Detect Metastatic Prostate Cancer in Patients - Mayo Clinic

    The purpose of this study is to examine PSMA and C-11 Choline PET in patients with suspected metastatic prostate cancer who have been imaged with 11C-Choline ...

  3. Stephen A. Boorjian, M.D. - Doctors and Medical Staff - Mayo Clinic

    TAP CaPSURE Scholarship for prostate cancer outcomes researchCancer of the Prostate Strategic Urologic Research Endeavor ... MemberProstate Cancer Risk Assessment ...

  4. Elisabeth I. Heath, M.D. - Mayo Clinic Faculty Profiles

    She specializes in prostate cancer research and care. As chair of the Division of Oncology Research, Dr. Heath brings more than two decades of experience in ...

  5. A Study to Evaluate the Safety and Effectiveness of Hypofractionation Proton Beam Therapy in Patients with Clinically Localized, Intermediate, or High Risk Prostate Cancer

    Previous or concurrent malignancy other than non-melanoma skin cancer within 5 years of diagnosis of prostate cancer; Inability to start the protocol ...

  6. Ruqin Chen, M.D., M.B. - Doctors and Medical Staff - Mayo Clinic

    Expertise in management of solid tumor malignancy such as prostate cancer, bladder cancer, kidney cancer, melanoma, etc. · Complex coordination of care for ...

  7. Living With Cancer: Identifying melanoma - Mayo Clinic News Network

    However, cancer is just one of several possible causes of increased prostate-specific antigen levels. After any procedure for an enlarged prostate, a number of ...

  8. Publications - Mark A. Nathan, M.D. - Mayo Clinic

    ... prostate cancer and prostate-specific antigen View PubMed; Lehman VT, Diehn FE, Broski SM, Nathan MA, Kemp BJ, Larson NB, Shelerud RA, Brault JS, Halasy MP ...

  9. Flutamide (oral route) - Side effects & dosage - Mayo Clinic

    Flutamide is used together with a luteinizing hormone-releasing hormone (LHRH) agonist to treat metastatic (cancer that has spread) prostate cancer in men.

  10. Living With Cancer: Treating skin cancer - Mayo Clinic News Network

    Prostatectomy includes a number of surgical procedures to remove part or all of the prostate gland. ... Most often, prostatectomy is performed to treat localized ...